Search
Search Results
##search.searchResults.foundPlural##
-
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1035PDF: 469HTML: 8135 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
668PDF: 786PDF Supp. Files: 69HTML: 170 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3999PDF: 1534HTML: 836 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2736PDF: 899HTML: 7300 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2079PDF: 1740HTML: 119 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3212PDF: 2220HTML: 23290Untitled: 186Untitled: 191Untitled: 210 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3157PDF: 1300HTML: 4104 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2759PDF: 1537HTML: 216 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1129PDF: 806HTML: 3343 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1036PDF: 384HTML: 218 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4295PDF: 870HTML: 1299Table1: 165 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
890PDF: 558HTML: 2178Cover Letter: 174 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12240PDF: 1631HTML: 4141Cover letter: 181Figure 1: 175 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1856PDF: 1125HTML: 248 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3209PDF: 1309HTML: 2608 -
-
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
807PDF: 477HTML: 1283 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1438PDF: 353HTML: 183 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1729PDF: 780HTML: 10206Figures 1,2,3: 152 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
2477PDF: 1759HTML: 220 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1131PDF: 684Html: 79 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1683PDF: 1042HTML: 227 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3654PDF: 1519HTML: 8005Randi Fig: 160 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2973PDF: 836HTML: 7150Kost Fig1: 164Kost Fig 2: 156Kost Fig3: 151Kost Fig 4: 169Kost Fig5: 166Kost fig 6: 151 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1375PDF: 1006HTML: 207 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1109PDF: 582HTML: 6783







